Biora Therapeutics (BIOR)
Biora Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company offers NaviCap, a...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- 0.2200
- Volume
- 0
- Turnover
- 0
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- 19.9000
- Volume Ratio
- 0.00
- Turnover Ratio
- --
News
- prnewswire · Apr 20 at 10:40 AM
11:39 ETNOTICE OF THE ANNUAL GENERAL MEETING OF BIORETEC LTD
- prnewswire · Apr 13 at 02:00 PM
15:00 ETBioOra and Cincinnati Children's Hospital Medical Center Partner to Advance Next-Generation CAR-T Therapy for Children with Leukaemia
- biopharmadive · Apr 7 at 09:23 AM
AI HealthTech Biorce Opens U.S. Offices in Austin to Accelerate Global Expansion
- biopharmadive · Apr 7 at 09:18 AM
BioOra and Octane Biotech Sign Letter of Intent to Expand Cell Therapy Manufacturing Using the Cocoon® Platform
- StockTitan · Apr 6 at 05:05 AM
UPSHER-SMITH LAUNCHES GENERIC VERSION OF CIPRODEX® (CIPROFLOXACIN 0.3% AND DEXAMETHASONE 0.1%) STERILE OTIC SUSPENSION | BORAY Stock News
- prnewswire · Apr 2 at 08:49 AM
09:47 ETBioretec Ltd publishes an exemption document relating to its rights issue
